Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
about
Ethical challenges with the left ventricular assist device as a destination therapyThe future of left ventricular assist devicesLeft ventricular assist device patient selection: do risk scores help?Mechanical Ventricular Assistance as Destination Therapy for End-Stage Heart Failure: Has it Become a First Line Therapy?Ethical dilemmas surrounding the use of ventricular assist devices in supporting patients with end-stage organ dysfunctionTemporary mechanical circulatory support: a review of the options, indications, and outcomesFunctional status in left ventricular assist device-supported patients: a literature reviewLeft ventricular assist devices as a bridge to cardiac transplantation.Inhaled therapy for the management of perioperative pulmonary hypertensionMechanical Circulatory Support for the Failing Heart: Continuous-Flow Left Ventricular Assist Devices.Left ventricular assist devices-current state and perspectivesLeft Ventricular Assist Devices for Destination Therapy: A Health Technology AssessmentCurrent state-of-the-art of device therapy for advanced heart failureRegional differences in use and outcomes of left ventricular assist devices: Insights from the Interagency Registry for Mechanically Assisted Circulatory Support RegistryManagement of end-stage heart failure: a perspective on the Arab Gulf statesPalliative Medicine and Preparedness Planning for Patients Receiving Left Ventricular Assist Device as Destination Therapy-Challenges to Measuring Impact and Change in Institutional Culture.Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapyThe Right Ventricular Function After Left Ventricular Assist Device (RVF-LVAD) study: rationale and preliminary resultsOPTN/SRTR 2011 Annual Data Report: heart.Low Accuracy of the HeartMate Risk Score for Predicting Mortality Using the INTERMACS Registry Data.Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support.Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fractionChronic heart failure: contemporary diagnosis and managementPreoperative serum albumin levels predict 1-year postoperative survival of patients undergoing heart transplantation.Relation of preoperative serum albumin levels to survival in patients undergoing left ventricular assist device implantation.Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation.Ventricular assist device implant in the elderly is associated with increased, but respectable risk: a multi-institutional study.Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era.Early adverse events as predictors of 1-year mortality during mechanical circulatory support.Assessing technological change in cardiothoracic surgery.Predictors of hospital length of stay after implantation of a left ventricular assist device: an analysis of the INTERMACS registry.Mechanical circulatory support as a bridge to transplant or for destination therapy.Survival analysis of patients with heart failure: implications of time-varying regression effects in modeling mortality.Initial experience with off-pump left ventricular assist device implantation in single center: retrospective analysisCardiac Health Risk Stratification System (CHRiSS): a Bayesian-based decision support system for left ventricular assist device (LVAD) therapy.Cardiac T-Tubule Microanatomy and Function.How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trialPredictors of right ventricular failure after left ventricular assist device implantation.Right ventricular function and left ventricular assist device placement: clinical considerations and outcomes.HeartWare and HeartMate II left ventricular assist devices as bridge to transplantation: a comparative analysis.
P2860
Q21203533-B6EA96E0-2D6A-4E1F-AB06-FA6A80F58F96Q26770276-452CDECB-B5F4-4287-B41B-4F9C597DFDDBQ26770320-A4A577C0-D64C-4B1B-8833-B5DB2A0BE741Q26797254-19E1B940-AD5D-43A1-95DB-678CEDBA8E3EQ26824420-E079247F-1441-4B2A-B0E7-A0001166A9DAQ26824537-2F56B85A-99C3-49EB-B4A0-9367526C2BECQ26995718-89CB52E8-B1E5-42B3-90F1-7ED4C9AA684EQ26999337-FB7F0200-8F2B-496C-A953-5CA509E1A0AAQ27026522-3B302323-AD24-4A9E-ACDB-E161DF962E37Q28071544-0422F447-3445-4C20-94B5-92F362BC86A9Q28074655-54A12505-6202-4AC6-A23C-2A1156155EDEQ28075310-02C491EE-35D9-46C3-B389-918EE282EE86Q28081412-840DA958-1047-4FF2-B801-22119D9A87A6Q28648127-892096AA-9301-430B-AE0E-010B7A6C084AQ28751716-C9A48AD6-5A34-458D-B8FD-06769309E9E4Q30151465-79164F89-064E-4396-9ACA-C405C72F7DD8Q30226555-04D978E5-A211-49C7-8FA1-563DD0F0DA9EQ30359726-D7FBAB34-998D-4868-A6E9-B8CC65BD2818Q30581476-F05BE6BC-E3D4-4100-83C7-AE97C4B733D8Q31149536-89F24EE0-0B92-465C-9C43-6BE5246FD567Q33390013-5960C698-C946-4191-8CF9-B11D5A769A3DQ33552944-9F83BC1A-0B70-45A8-BB79-B1CF8DBA16B9Q33620431-7C1E7274-9CA8-45DA-8BA0-7022F2B3A7D9Q33818484-B19441EF-7BD6-4C16-97D7-C0866F49A871Q33818507-BA3DAADE-A7FD-4CE9-9965-0D9F745648C8Q33920259-EA7AF65D-D7CC-432D-9A43-FD34791FDEA6Q33951313-7A48F9A8-A15B-43BF-B332-A06ED207FC09Q33951353-C081099D-07F8-496E-866E-BAAAF7208E10Q34079591-AABA97FC-8F09-49D5-8EE5-FA6D21D88EFEQ34111912-2375FCC2-2C09-4C51-96AB-4F001EC669D3Q34240752-3876D06A-929C-4CD4-B356-D68447315A2BQ34268754-CE486302-06CA-474D-A8E4-0DD61ED4E6E8Q34310212-9793299E-C3FC-4651-AEE3-4712F40C9E57Q34467873-24E0C341-6E80-40B8-8BD0-A9296E351E58Q34513055-C052C4D5-EA03-4ACC-8563-994AF833D7CEQ34545692-E72448D9-0515-4D58-B5AB-77A4B5723041Q34609578-56F0E94E-6353-44B6-85C0-C482C9572E1EQ34965572-0F74FDDD-8FB7-45A5-AF43-09B86DE8AEADQ34986270-C108E9F9-FEB8-4C02-822C-D1F9DD5B5177Q35029983-6762F976-595B-4FC0-9853-BE56209C1FD8
P2860
Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Outcomes of left ventricular a ...... cations for patient selection.
@en
Outcomes of left ventricular a ...... cations for patient selection.
@nl
type
label
Outcomes of left ventricular a ...... cations for patient selection.
@en
Outcomes of left ventricular a ...... cations for patient selection.
@nl
prefLabel
Outcomes of left ventricular a ...... cations for patient selection.
@en
Outcomes of left ventricular a ...... cations for patient selection.
@nl
P2093
P1433
P1476
Outcomes of left ventricular a ...... cations for patient selection.
@en
P2093
Abdallah G Kfoury
Carmelo A Milano
Donna Mancini
James W Long
Joseph G Rogers
Katherine Lietz
Leslie W Miller
Marc A Silver
Mark S Slaughter
Yoshifumi Naka
P304
P356
10.1161/CIRCULATIONAHA.107.691972
P407
P577
2007-07-16T00:00:00Z